Co Diagnostics Stock Filter Stocks by Fundamentals
| CODX Stock | USD 0.39 0.02 4.88% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Co Diagnostics' long-term financial health and intrinsic value.
CODX | Shares Owned by Insiders | Build AI portfolio with CODX Stock |
Co Diagnostics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Co Diagnostics from analyzing Co Diagnostics' financial statements. These drivers represent accounts that assess Co Diagnostics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Co Diagnostics' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 248.5M | 257.8M | 79.3M | 39.0M | 22.8M | 21.6M | |
| Enterprise Value | 205.5M | 169.2M | 56.7M | 27.1M | 22.0M | 20.9M |
Co Diagnostics Institutional Holders
Institutional Holdings refers to the ownership stake in Co Diagnostics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Co Diagnostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Co Diagnostics' value.| Shares | Uma Financial Services Inc | 2025-06-30 | 28.4 K | Smi Advisory Services Llc | 2025-06-30 | 28 K | Virtu Financial Llc | 2025-06-30 | 25.6 K | Rathbone Brothers Plc | 2025-06-30 | 25 K | Envestnet Asset Management Inc | 2025-06-30 | 16.5 K | Regal Investment Advisors Llc | 2025-06-30 | 15 K | Jpmorgan Chase & Co | 2025-06-30 | 14.2 K | Hrt Financial Llc | 2025-06-30 | 13.3 K | Triton Wealth Management, Pllc | 2025-06-30 | 11.1 K | Vanguard Group Inc | 2025-06-30 | 1.7 M | Private Asset Group Llc | 2025-06-30 | 1.2 M |
CODX Fundamentals
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.38 | ||||
| Operating Margin | (49.46) % | ||||
| Current Valuation | 5.43 M | ||||
| Shares Outstanding | 60.14 M | ||||
| Shares Owned By Insiders | 5.04 % | ||||
| Shares Owned By Institutions | 11.68 % | ||||
| Number Of Shares Shorted | 111.95 K | ||||
| Price To Earning | 6.78 X | ||||
| Price To Book | 0.42 X | ||||
| Price To Sales | 24.34 X | ||||
| Revenue | 3.92 M | ||||
| Gross Profit | 397.49 K | ||||
| EBITDA | (38.7 M) | ||||
| Net Income | (37.64 M) | ||||
| Cash And Equivalents | 86.49 M | ||||
| Cash Per Share | 2.80 X | ||||
| Total Debt | 2.15 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 16.95 X | ||||
| Book Value Per Share | 1.14 X | ||||
| Cash Flow From Operations | (29.16 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (1.15) X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 132 | ||||
| Beta | 1.15 | ||||
| Market Capitalization | 24.42 M | ||||
| Total Asset | 64 M | ||||
| Retained Earnings | (33.04 M) | ||||
| Working Capital | 24.98 M | ||||
| Current Asset | 858.78 K | ||||
| Current Liabilities | 2.84 M | ||||
| Net Asset | 64 M |
About Co Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Co Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Co Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Co Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.